Case finding and screening strategies for thyroid dysfunction
- PMID: 11728414
- DOI: 10.1016/s0009-8981(01)00715-x
Case finding and screening strategies for thyroid dysfunction
Abstract
Background: A case can be made for routine testing for thyroid dysfunction (TD) in women aged over 50 years once every 5 years when they present for medical care (case finding). This recommendation is based on: (i) the prevalence of TD, predominantly hypothyroidism, (ii) the insensitivity of standard clinical assessment in detecting even overt TD, (iii) the sensitivity of a single test, serum thyroid stimulating hormone (TSH), in identifying both over- and under-function, (iv) the probable adverse consequences of failure to recognize even mild TD, (v) the safety and effectiveness of treatment, and (vi) presumed lack of adverse effect from the testing program.
Methods: A normal serum TSH value has a high negative predictive value in ruling out primary TD; if TSH is abnormal, measurement of serum free thyroxine (T(4)) and further clinical assessment are both required to establish the degree of TD.
Results: Case finding identifies more "subclinical" or mild TD (abnormal TSH, normal T(4) and triiodothyronine (T(3))), than overt disease, but a major benefit of widespread testing is the earlier detection and treatment of unsuspected overt disease. There is now evidence that mild TD has adverse consequences and should not merely be regarded as a prognostic indicator, but there is still no consensus whether there is a causal relationship between mild thyroid failure and dyslipidemia.
Conclusions: A case can be made for treatment of both mild thyrotoxicosis and hypothyroidism, but the therapeutic decision is generally simpler for hypothyroidism.
Similar articles
-
Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.JAMA. 1996 Jul 24-31;276(4):285-92. JAMA. 1996. PMID: 8656540
-
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.JAMA. 2004 Jan 14;291(2):228-38. doi: 10.1001/jama.291.2.228. JAMA. 2004. PMID: 14722150 Review.
-
Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation.Horm Metab Res. 1990 May;22(5):298-302. doi: 10.1055/s-2007-1004906. Horm Metab Res. 1990. PMID: 2112111
-
[Subclinical thyroid disease--should we treat, should we screen for it?].Srp Arh Celok Lek. 2003 Nov-Dec;131(11-12):467-73. Srp Arh Celok Lek. 2003. PMID: 15114790 Review. Serbian.
-
Two-step thyroid screening strategy in the critical patient.Clin Biochem. 2016 Aug;49(12):925-8. doi: 10.1016/j.clinbiochem.2016.05.013. Epub 2016 May 18. Clin Biochem. 2016. PMID: 27208556
Cited by
-
Human immunodeficiency virus, diabetes mellitus and thyroid abnormalities: Should we be screening?South Afr J HIV Med. 2020 Nov 9;21(1):1116. doi: 10.4102/sajhivmed.v21i1.1116. eCollection 2020. South Afr J HIV Med. 2020. PMID: 33240534 Free PMC article.
-
Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.Arch Pathol Lab Med. 2014 Feb;138(2):189-203. doi: 10.5858/arpa.2013-0149-OA. Epub 2013 Jun 5. Arch Pathol Lab Med. 2014. PMID: 23738761 Free PMC article.
-
Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes.Fertil Steril. 2011 Jun 30;95(8):2634-7. doi: 10.1016/j.fertnstert.2011.02.056. Epub 2011 Mar 31. Fertil Steril. 2011. PMID: 21457968 Free PMC article.
-
Retinoic acid reverses the PTU related decrease in neurogranin level in mice brain.J Physiol Biochem. 2004 Sep;60(3):191-8. doi: 10.1007/BF03167028. J Physiol Biochem. 2004. PMID: 15700765
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
